drugset / Trial / NCT00096785

Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection

NCT00096785

Phase 3 Completed 69 enrolled Bristol-Myers Squibb
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate antiviral activity and efficacy of entecavir (ETV) compared to adefovir in adults with chronic hepatitis B who have not been treated yet with an antiviral medicine.

Timeline

Start
2004-12
Primary completion
2006-01
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adefovir Unknown 10 mg Oral
Comparator Entecavir Small molecule 0.5 mg Oral